Autism Spectrum Disorder Trial, Recruiting NCT04638452 Sponsor: Centre Hospitalier Charles Perrens, Bordeaux Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT04638452
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 6 years of age
  • People who agree to take part in the study
  • People who are members of the social security scheme
  • People who have not taken any pain-relief medication that could affect how pain is felt
  • People who have a doctor's order for a blood test
  • (For participants with autism spectrum disorder only) People who have a formal diagnosis of autism spectrum disorder (ASD)
  • (For participants with autism spectrum disorder only) Where relevant, a legal guardian or authorized representative has also given consent to participate

Who may not be able to join:

  • People whose medication has not been stabilized
  • People who are currently experiencing short-term or long-term pain
  • People who have a condition or are taking a treatment that could change how pain is experienced
  • People who have difficulties controlling eye movement or other movement-related neurological conditions
  • People who are pregnant or breastfeeding
  • People who are currently under legal detention or deprivation of liberty
  • People who do not agree to take part or do not agree to being video recorded during the study
  • (For participants without ASD only) People who are adults under legal protection orders
  • (For participants without ASD only) People who have a diagnosis of autism spectrum disorder (ASD)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anouck AMESTOY, MD, Physician

Phone: 0556566719

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Registry
ClinicalTrials.gov
Start date
8 February 2021
Est. completion
30 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Facial expression during blood sample; Body movement during blood sample

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov